Ondansetron ODT 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3GN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,776
Award facts
- Contract value 100% obligated
- $8,775.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,775.67 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) on January 13, 2026, with completion scheduled for January 14, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is to be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order falls under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for pharmaceutical and medical supply distribution to support military healthcare programs globally.
Ondansetron is a widely used antiemetic medication commonly prescribed for nausea and vomiting management, particularly in military and veteran healthcare settings. AmerisourceBergen Drug Corp, operating as a subsidiary of Cencora, Inc., maintains a substantial federal procurement presence as a critical pharmaceutical distributor for the Defense Logistics Agency and other federal health systems. The vendor's extensive portfolio demonstrates consistent capability in fulfilling diverse pharmaceutical supply requirements across multiple therapeutic domains through open competition, making it a key vendor for federal medical procurement operations.
Quick answers
Who was awarded contract SPE2DR26FG3GN?
SPE2DR26FG3GN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FG3GN worth?
The government has obligated $8,776 on SPE2DR26FG3GN.
Is contract SPE2DR26FG3GN an order under another contract?
Yes. SPE2DR26FG3GN is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3GN competed?
The extent of competition for SPE2DR26FG3GN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award